ResMed
RMD
$0.43 (-0.18%)
1D
1W
3M
1Y
5Y
ALL
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
GlobeNewsWire • 3 hours ago • RMD
ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024Seeking Alpha • 7 hours ago • RMD
My Top 15 High Growth Dividend Stocks For October 2024Zacks Investment Research • 1 day ago • RMD
ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 1 day ago • RMD
Scoop up These 4 GARP Stocks to Receive Handsome ReturnsZacks Investment Research • 2 days ago • RMD
RMD Stock Likely to Gain From Enhanced Digital Sleep Health SolutionsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.